Quest Diagnostics Incorporated (DGX) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Quest Diagnostics shareholders at a glance

The largest holder of Quest Diagnostics stock is Vanguard Capital Management LLC, with 7.2 million shares (6.55% of the company), worth about $1.74 billion as of September 25, 2026. The 10 largest holders together own 43.1%.

In Q2 2026, 1,141 institutional holdings reports listed shares worth $22.30 billion.

Insiders reported 98 transactions in the last two years: 30 sales worth $42.20 million and 18 purchases. The newest one on file is from April 20, 2026 (Plewman Patrick, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through April 20, 2026.

DGX logo

Quest Diagnostics Incorporated

DGXUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
1141
Options Value
$133.00M
Value (excl. Options)
$22.30B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Quest Diagnostics shareholders

HolderShares% of companyValue
Vanguard Capital Management LLC7.2 million6.55%$1.7B
BlackRock Advisors LLC7.2 million6.50%$1.7B
Vanguard Portfolio Management LLC6.1 million5.55%$1.5B
State Street Corporation5.5 million5.00%$1.3B
T. Rowe Price International Ltd.5.4 million4.93%$1.3B
Boston Partners Global Investors, Inc.4.7 million4.30%$1.1B
JPMorgan Investment Management, Inc.3.5 million3.19%$846.0M
Geode Capital Management LLC3.1 million2.84%$754.0M
Eaton Vance Management2.5 million2.23%$591.0M
Edgepoint Investment Group, Inc.2.2 million2.04%$540.0M

As of September 25, 2026.

Quest Diagnostics institutional holdings by quarter

QuarterReportsSharesValue
Q2 20261,141–$22.3B
Q1 20261,090103.0 million$20.1B
Q4 20251,080107.0 million$18.4B
Q3 20251,041109.0 million$20.8B
Q2 20251,030109.0 million$19.5B
Q1 20251,008104.0 million$17.5B
Q4 202493599.6 million$15.0B
Q3 2024886101.0 million$15.5B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Quest Diagnostics insider trades

InsiderDateTitleTransactionValue
Plewman PatrickApr 20, 2026OfficerPurchase at price 194.70 per share.$9,540
Lassiter Wright IiiApr 20, 2026DirectorPurchase at price 194.70 per share.$1,168
Kuppusamy KarthikApr 20, 2026OfficerPurchase at price 194.70 per share.$7,593
Delaney Mark EApr 20, 2026OfficerPurchase at price 194.70 per share.$7,204
Gregg Vicky BApr 20, 2026DirectorStock Award(Grant) at price 194.70 per share.$13,239
Samad Samer AbdulApr 20, 2026Chief Financial OfficerStock Award(Grant) at price 194.70 per share.$21,027
Wentworth Timothy CharlesMar 9, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Plewman PatrickMar 5, 2026OfficerSale at price 206.21 per share.$588,730
Doherty Catherine TMar 5, 2026OfficerSale at price 206.21 per share.$1.1M
Prevoznik Michael EMar 5, 2026General CounselSale at price 206.21 per share.$799,682
Samad Samer AbdulMar 4, 2026Chief Financial OfficerStock Award(Grant) at price 204.86 per share.$2.9M
Deppe Michael JMar 4, 2026OfficerStock Award(Grant) at price 204.86 per share.$301,759

Newest 12 of 98 insider transactions in the last two years.

Questions and answers

Who owns the most Quest Diagnostics stock?

Vanguard Capital Management LLC, with 6.55% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.50%) and Vanguard Portfolio Management LLC (5.55%).

How many institutions own Quest Diagnostics stock?

1,141 institutional holdings reports listed Quest Diagnostics shares in Q2 2026 worth $22.30 billion.

Are Quest Diagnostics insiders buying or selling the stock?

In the last two years insiders reported 30 sales and 18 purchases (98 transactions in all); the newest on file is from April 20, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube